中西医结合研究
中西醫結閤研究
중서의결합연구
RESEARCH OF INTEGRATED TRADITIONAL CHINESE AND WESTERN MEDICINE
2014年
5期
225-230
,共6页
李金花%赵恒侠%李增英%郑夏洁%刘显畅
李金花%趙恆俠%李增英%鄭夏潔%劉顯暢
리금화%조항협%리증영%정하길%류현창
荷芪散%代谢综合征%痰瘀证%量效分析
荷芪散%代謝綜閤徵%痰瘀證%量效分析
하기산%대사종합정%담어증%량효분석
He Qi San%metabolic syndrome%phlegm-blood stasis syndrome%analysis of dose-effect relationship
目的:临床观察荷芪散不同剂量治疗代谢综合征痰瘀证的疗效。方法入选120例代谢综合征患者,对照组采用西药治疗方案,治疗组患者随机分为低、中、高剂量3个组,给予口服相应剂量的中药荷芪散,观察治疗前后各组中医证候积分、人体参数及血脂代谢指标(TG、TC、LDL)的变化。结果荷芪散能有效改善中医证侯指标,尤其以中、高剂量组效果明显,且治疗30 d后显效更明显;治疗组控制体重指数(BMI)较对照组显著(P<0.05),且中、高剂量组疗效更显著(P<0.05);治疗组在降低餐后2 h血糖(P2hBG)较对照组显著(P<0.05),而降低空腹血糖(FPG)差异无统计学意义(P>0.05);治疗后,治疗组餐后2 h胰岛素(P2hINS)降低(P<0.05),高剂量组降低更明显(P<0.05),而对照组治疗前后餐后2 h胰岛素水平差异无统计学意义(P>0.05);治疗组 TG、TC、LDL 水平降低较对照组显著(P<0.01),且中、高剂量组 TG、TC水平降低差异有统计学意义(P<0.05),而不同剂量组间LDL水平降低量效关系差异无统计学意义(P>0.05);对照组和治疗组均不能改善 HDL 水平(P>0.05);治疗组降低瘦素(LEP)、肿瘤坏死因子(TNF)水平和升高脂联素(APN)水平较对照组显著(P<0.05),且中剂量组差异更显著( P<0.05)。结论荷芪散能降低中医证候积分,有效缓解临床症状,能显著控制BMI ,调整糖、脂代谢紊乱,减轻胰岛素抵抗,降低LEP ,升高APN 水平,减少 TNF的分泌,荷芪散不会引起高胰岛素血症,在降低BP、改善 HDL水平等方面无明显优势。本研究结果亦提示,荷芪散在临床处方中无需过量使用,中剂量即可达到满意的疗效。
目的:臨床觀察荷芪散不同劑量治療代謝綜閤徵痰瘀證的療效。方法入選120例代謝綜閤徵患者,對照組採用西藥治療方案,治療組患者隨機分為低、中、高劑量3箇組,給予口服相應劑量的中藥荷芪散,觀察治療前後各組中醫證候積分、人體參數及血脂代謝指標(TG、TC、LDL)的變化。結果荷芪散能有效改善中醫證侯指標,尤其以中、高劑量組效果明顯,且治療30 d後顯效更明顯;治療組控製體重指數(BMI)較對照組顯著(P<0.05),且中、高劑量組療效更顯著(P<0.05);治療組在降低餐後2 h血糖(P2hBG)較對照組顯著(P<0.05),而降低空腹血糖(FPG)差異無統計學意義(P>0.05);治療後,治療組餐後2 h胰島素(P2hINS)降低(P<0.05),高劑量組降低更明顯(P<0.05),而對照組治療前後餐後2 h胰島素水平差異無統計學意義(P>0.05);治療組 TG、TC、LDL 水平降低較對照組顯著(P<0.01),且中、高劑量組 TG、TC水平降低差異有統計學意義(P<0.05),而不同劑量組間LDL水平降低量效關繫差異無統計學意義(P>0.05);對照組和治療組均不能改善 HDL 水平(P>0.05);治療組降低瘦素(LEP)、腫瘤壞死因子(TNF)水平和升高脂聯素(APN)水平較對照組顯著(P<0.05),且中劑量組差異更顯著( P<0.05)。結論荷芪散能降低中醫證候積分,有效緩解臨床癥狀,能顯著控製BMI ,調整糖、脂代謝紊亂,減輕胰島素牴抗,降低LEP ,升高APN 水平,減少 TNF的分泌,荷芪散不會引起高胰島素血癥,在降低BP、改善 HDL水平等方麵無明顯優勢。本研究結果亦提示,荷芪散在臨床處方中無需過量使用,中劑量即可達到滿意的療效。
목적:림상관찰하기산불동제량치료대사종합정담어증적료효。방법입선120례대사종합정환자,대조조채용서약치료방안,치료조환자수궤분위저、중、고제량3개조,급여구복상응제량적중약하기산,관찰치료전후각조중의증후적분、인체삼수급혈지대사지표(TG、TC、LDL)적변화。결과하기산능유효개선중의증후지표,우기이중、고제량조효과명현,차치료30 d후현효경명현;치료조공제체중지수(BMI)교대조조현저(P<0.05),차중、고제량조료효경현저(P<0.05);치료조재강저찬후2 h혈당(P2hBG)교대조조현저(P<0.05),이강저공복혈당(FPG)차이무통계학의의(P>0.05);치료후,치료조찬후2 h이도소(P2hINS)강저(P<0.05),고제량조강저경명현(P<0.05),이대조조치료전후찬후2 h이도소수평차이무통계학의의(P>0.05);치료조 TG、TC、LDL 수평강저교대조조현저(P<0.01),차중、고제량조 TG、TC수평강저차이유통계학의의(P<0.05),이불동제량조간LDL수평강저량효관계차이무통계학의의(P>0.05);대조조화치료조균불능개선 HDL 수평(P>0.05);치료조강저수소(LEP)、종류배사인자(TNF)수평화승고지련소(APN)수평교대조조현저(P<0.05),차중제량조차이경현저( P<0.05)。결론하기산능강저중의증후적분,유효완해림상증상,능현저공제BMI ,조정당、지대사문란,감경이도소저항,강저LEP ,승고APN 수평,감소 TNF적분비,하기산불회인기고이도소혈증,재강저BP、개선 HDL수평등방면무명현우세。본연구결과역제시,하기산재림상처방중무수과량사용,중제량즉가체도만의적료효。
Objective To observe the curative effect of different doses of He Qi San in treating the metabolic syndrome with phlegm‐blood stasis syndrome.Methods We collected 120 cases of the metabolic syndrome with phlegm‐blood stasis syndrome. The treatment groups were randomly divided into low‐dose ,middle‐dose and high‐dose groups ,taking different doses of He Qi San respectively ,while without any traditional Chinese medicine for the patients in the control group. We assessed the TCM syndrome integral and measured the human parameters and metabolic indexs of all patients ,both before and after the treatment.Results The TCM curative effect of this stud‐y showed that He Qi San can effectively improve the TCM syndrome indicators ,especially in middle‐dose group and high‐dose group. The curative effect was especially obvious after 30 days.Compared with the control group ,the treatment groups controled body weight better(P<0.05) ,obviously in middle‐dose group and high‐dose group(P<0.05). However ,there was no difference between the control group and the treatment group in decreasing waists and blood pressure(P>0.05) ,and the dose‐effect relationships were not obvious in three treatment groups(P<0.05). The treatment group acted much better than the control group in lowering postprandial glucose(P<0.05) , particularly in middle‐dose group and high‐dose group(P< 0.05) ,but without obvious effect in reducing fasting glucose(P> 0.05).The treatment group reduced postprandial insulin significantly(P< 0.05) ,with more obvious effect in high‐dose group(P<0.05).Whereas ,there was no obvious change in the insulin level of the control group after the treatment(P>0.05). TG ,TC and LDL levels reduced obviously in the treatment groups(P<0.05 ,P<0.01). TG and TC levels reduced particularly obviously in middle‐dose group and high‐dose group(P<0.05).Both groups could not improve HDL levels(P>0.05). Treatment group could strikly lower levels of leptin and tumor necrosis factor(TNF)and elevate adiponectin level(P< 0.05 ,P< 0.01) ,especially in low‐dose group(P< 0.05) . The clinical curative effect of most indexs in this study showed that there was no significant difference between middle‐dose group and high‐dose group.Conclusion The results showed that He Qi San can reduce TCM syn‐drome integral and relieve clinical symptoms effectively.It can significantly control body weight ,adjust the meta‐bolic disorder and relieve insulin resistance.It can also reduce the secretion of leptin and TNF and increase the level of adiponectin.The curative effect of middle dose and high dose of He Qi San are more ideal and comparable.In ad‐dition ,the results show ed that He Qi San doesn't cause hyperinsulinemia. How ever ,there w as no obvious advantage of He Qi San in low ering blood pressure and improving HDL levels. In conclusion ,this study suggests that He Qi San with middle dose can achieve satisfactory curative effect in clinical prescription.